Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)

Recruiting

Phase 1

Phase 2

Microbiome 2Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)

Sponsor:

National Institute of Allergy and Infectious Diseases (NIAID)

Code:

NCT06504160

Conditions

Atopic Dermatitis

Eligibility Criteria

Sex: All

Age: 12+

Healthy Volunteers: Not accepted

Interventions

ShA9 Topical Gel

Hydrocortisone Ointment

Clobetasol Ointment

Fluocinonide Ointment

Placebo (Vehicle) Topical Gel

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-01. This information was provided to ClinicalTrials.gov by National Institute of Allergy and Infectious Diseases (NIAID) on 2025-04-25.